Best Approaches and Emerging Data in the Treatment of Non-Clear Cell RCC
The panel discusses the best approaches to treating patients with non-clear cell RCC.
Source: onclive.com
Page 4 - Dose Reduction News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Dose Reduction. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Dose Reduction Today - Breaking & Trending Today
Practical Considerations for Managing RR DTC With Systemic Therapy
Comprehensive insight on best practices in dose adjustment and adverse event management in patients receiving systemic therapy for RR DTC.
Source: onclive.com
Patient Scenario 1: RR DTC Managed With Frontline Lenvatinib
Expert Marcia Brose, MD, PhD, reviews a patient case of radioiodine-refractory differentiated thyroid cancer (RR DTC) managed with frontline lenvatinib therapy.
Source: onclive.com
Treatment Approaches for Patients with RCC Disease Progression After Adjuvant Therapy
Mehmet Asim Bilen, MD, explains how he would treat a patient with renal cell carcinoma who had disease progression after adjuvant therapy.
Source: onclive.com
Updates in the Adjuvant Treatment of Metastatic RCC
The panel discusses recent clinical trial data in the adjuvant treatment of metastatic renal cell carcinoma.
Source: onclive.com